Comparative evaluation of assays for IgM detection of rubella and measles infections.

Chemiluminescent immunoassay Electrochemiluminescent immunoassay Enzyme immunoassay Inmunoensayo electroquimioluminiscente Inmunoensayo enzimático Inmunoensayo quimioluminiscente Measles virus Rubella virus Virus rubéola Virus sarampión

Journal

Enfermedades infecciosas y microbiologia clinica (English ed.)
ISSN: 2529-993X
Titre abrégé: Enferm Infecc Microbiol Clin (Engl Ed)
Pays: Spain
ID NLM: 101777541

Informations de publication

Date de publication:
19 Aug 2020
Historique:
received: 15 04 2020
revised: 18 06 2020
accepted: 23 06 2020
entrez: 24 8 2020
pubmed: 24 8 2020
medline: 24 8 2020
Statut: aheadofprint

Résumé

Serological diagnosis of infections due to measles and rubella viruses is done by IgM detection. The aim of this study was to comparatively evaluate commercial systems for detecting IgM against both viruses, including those of ELISA, in indirect and capture formats, chemiluminescence and electrochemiluminescence. Seven (for rubella) and six (for measles) assays were studied. One hundred and sixty two samples were included in the study (from 90 rubella and 72 measles cases), and all were analyzed in all the assays. The ranges of sensitivity, specificity and agreement for rubella were 94.8-100%, 52.4-100% and 75.5-98.1%, respectively. The corresponding ranges for measles assays were 87.0-100%, 53.3-100%, and 73.0-99.4%. The best-performing assays were chemiluminescence (for measles and rubella IgM), and electrochemiluminescence (for rubella IgM).

Sections du résumé

BACKGROUND BACKGROUND
Serological diagnosis of infections due to measles and rubella viruses is done by IgM detection. The aim of this study was to comparatively evaluate commercial systems for detecting IgM against both viruses, including those of ELISA, in indirect and capture formats, chemiluminescence and electrochemiluminescence.
METHODS METHODS
Seven (for rubella) and six (for measles) assays were studied. One hundred and sixty two samples were included in the study (from 90 rubella and 72 measles cases), and all were analyzed in all the assays.
RESULTS RESULTS
The ranges of sensitivity, specificity and agreement for rubella were 94.8-100%, 52.4-100% and 75.5-98.1%, respectively. The corresponding ranges for measles assays were 87.0-100%, 53.3-100%, and 73.0-99.4%.
CONCLUSION CONCLUSIONS
The best-performing assays were chemiluminescence (for measles and rubella IgM), and electrochemiluminescence (for rubella IgM).

Identifiants

pubmed: 32828554
pii: S0213-005X(20)30256-1
doi: 10.1016/j.eimc.2020.06.019
pii:
doi:

Types de publication

Journal Article

Langues

eng spa

Sous-ensembles de citation

IM

Informations de copyright

Copyright © 2020 Sociedad Española de Enfermedades Infecciosas y Microbiología Clínica. Publicado por Elsevier España, S.L.U. All rights reserved.

Auteurs

Mayte Pérez Olmeda (M)

Laboratorio de Serología, Centro Nacional de Microbiología, Instituto de Salud Carlos III, Majadahonda, Spain.

Pilar Balfagón (P)

Laboratorio de Serología, Centro Nacional de Microbiología, Instituto de Salud Carlos III, Majadahonda, Spain.

Juan Camacho (J)

Laboratorio de Serología, Centro Nacional de Microbiología, Instituto de Salud Carlos III, Majadahonda, Spain.

Desirée Dafouz (D)

Laboratorio de Serología, Centro Nacional de Microbiología, Instituto de Salud Carlos III, Majadahonda, Spain.

Jesús de la Fuente (J)

Laboratorio de Serología, Centro Nacional de Microbiología, Instituto de Salud Carlos III, Majadahonda, Spain.

María Ángeles Murillo (MÁ)

Laboratorio de Serología, Centro Nacional de Microbiología, Instituto de Salud Carlos III, Majadahonda, Spain.

José Luis Muñoz (JL)

Laboratorio de Serología, Centro Nacional de Microbiología, Instituto de Salud Carlos III, Majadahonda, Spain.

Aurora Fernández García (A)

Laboratorio de Aislamiento Viral, Centro Nacional de Microbiología, Instituto de Salud Carlos III, Majadahonda, Spain; Centro de Investigación Biomédica en Red en Epidemiología y Salud Pública (CiberESP), Instituto de Salud Carlos III, Madrid, Spain.

Juan Carlos Sanz (JC)

Laboratorio Regional de Salud Pública de la Comunidad de Madrid, Madrid, Spain; Centro de Investigación Biomédica en Red en Epidemiología y Salud Pública (CiberESP), Instituto de Salud Carlos III, Madrid, Spain.

Fernando de Ory (F)

Laboratorio de Serología, Centro Nacional de Microbiología, Instituto de Salud Carlos III, Majadahonda, Spain; Centro de Investigación Biomédica en Red en Epidemiología y Salud Pública (CiberESP), Instituto de Salud Carlos III, Madrid, Spain. Electronic address: fernandodeorym@gmail.com.

Classifications MeSH